Onbo subcutaneous injection 100mg syringe, from Eli Lilly Japan, contains mirikizumab (genetical recombination). This IL-23 inhibitor is used to treat adults with moderate-to-severe ulcerative colitis and Crohn’s disease. It is supplied as 100mg x 1mL tube with YJ code 2399407G1024.
Onbo subcutaneous injection 100mg syringe
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →